Red List

ADMAADMA Biologics Inc

Healthcare · Biotechnology · small-cap ($1.9B)
-64.5%
from rolling 252-day high of $22.37 set 2025-06-11 · 351d ago
Current
$7.93
Decline depth
-64.5%
Decline σ
6.4σ
TFC
5/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$ADMA has been tracked since 2026-03-01. It was down 35.4% from its 52-week high then — now down -64.5%.

That's 32.6 percentage points deeper than the day it joined.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

ADMA qualifies for the Red List on decline depth.

Decline depth
-64.5%
From rolling 252-day high of $22.37, 351d ago. Past the 40% Red List threshold.
Time-frame continuity
5/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Full bearish continuity — every time frame is broken.
Decline sigma
6.4σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.3% per day). Past the ≥6σ Amber threshold.

The structural read

What price action says about ADMA.

ADMA qualifies for the Red List on decline depth — down -64.5% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 5/5 bearish time frames.

Cross-confirmation: decline sigma also reads 6.4σ over 20 bars.

Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 1 (green), weekly 2D (red), monthly 2D (red).

Earnings on file: 2026-05-06. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $7.21 4.7% of range 52W high $22.37

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

88 Red List
47 Amber
59 Watch
-35.8% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about ADMA

What people ask.

Why is ADMA on Broken Stocks?

ADMA qualifies for the Red List on decline depth. It is down -64.5% from its rolling 252-day high of $22.37, set on 2025-06-11 — 351d ago.

Is ADMA a falling knife?

Not by the strict technical definition. ADMA is down -64.5% from its 52-week high, but that high was set 351d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ADMA is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is ADMA a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is ADMA trading inside its 52-week range?

At $7.93, ADMA sits 4.7% of the way from its 52-week low ($7.21) to its 52-week high ($22.37). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has ADMA been declining?

The current 64.5% decline accrued over 351d, which annualizes to roughly -67.1% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does ADMA compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — ADMA's decline is deeper than the sector median.

Does ADMA's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.